Vaxcyte (PCVX) Price/Sales Ratio

Price: $35.38
Market Cap: $4.56B
Avg Volume: 2.02M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.264
52W Range: $27.66-121.055
Website: Vaxcyte

What is Vaxcyte's Price/Sales Ratio?

  • Vaxcyte's trailing twelve month (TTM) Price/Sales ratio is 0.00.
  • Vaxcyte's annual Price/Sales ratio as of today is 0.00.
  • Vaxcyte's quarterly Price/Sales ratio is 0.00.

What is the Price/Sales Ratio?

The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.

How is the Price/Sales Ratio calculated?

The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:

P/S Ratio = Market Capitalization / Total Sales (Revenue)

Related Metrics

Other important metrics to assess Vaxcyte's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: -21.53
    • Quarterly: -18.34
    • TTM: -9.37
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: 3.02
    • Quarterly: 3.04
    • TTM: 1.31
  • P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: -22.06
    • Quarterly: -90.27
    • TTM: -9.60
  • PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
    • Annual: 2.62
    • Quarterly: -0.52
    • TTM: -0.66

These metrics provide insights into Vaxcyte's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Price/Sales Ratio

0.00

Quarterly Price/Sales Ratio

0.00

TTM Price/Sales Ratio

0.00

Vaxcyte Historical Price/Sales Ratio
InfinityInfinity0.000.00Price/Sales Ratio2018201820192019202020202021202120222022202320232024202420252025
Historical P/E Ratio
0.000.00-5.00-5.00-10.00-10.00-15.00-15.00-20.00-20.00-25.00-25.00P/E Ratio2018201820192019202020202021202120222022202320232024202420252025
Historical P/B Ratio
6.006.004.004.002.002.000.000.00-2.00-2.00P/B Ratio2018201820192019202020202021202120222022202320232024202420252025
Historical P/C Ratio
0.000.00-2000.00-2000.00-4000.00-4000.00-6000.00-6000.00-8000.00-8000.00P/C Ratio2018201820192019202020202021202120222022202320232024202420252025
Historical PEG Ratio
3.003.002.002.001.001.000.000.00-1.00-1.00-2.00-2.00PEG Ratio2018201820192019202020202021202120222022202320232024202420252025

Vaxcyte Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Price/Sales Ratio P/E Ratio P/B Ratio P/C Ratio PEG Ratio
2024 0.00 -21.53 3.02 -22.06 2.62
2023 0.00 -15.17 4.92 -20.56 -1.24
2022 0.00 -12.98 3.26 -18.24 -0.14
2021 0.00 -12.34 4.35 -10.18 0.35
2020 0.00 -8.94 2.27 -16.84 0.11
2019 0.00 -1.85 -0.93 -2.10 -0.03
2018 0.00 -3.22 -1.64 -3.11 -0.05
2017 0.00 -5.41 3.01 -6230.35 0.00

Related Metrics

Explore detailed financial metrics and analysis for PCVX.